Cookie policy

This site uses cookies to improve your user experience. By using this website, you agree that we can place cookies on your device. For further information, please read our Privacy And Cookies Policy

I accept the terms and conditions
Skip Ribbon Commands
Skip to main content

Nanopass®

32.5G Needle for Pen Injectors

Description

Nanopass® 32.5G Pen Needle

Available in three lengths, Nanopass® 32.5G Pen Needles unique asymmetric bevel design is engineered to reduce the pain of frequent, regular injections. 1

Characteristics

  • ​Asymetric bevel1

  • Thin pen needle size

  • Terumo-thin wall technology

  • ​Colour coding

Patented design for all pen injector applications 


Nanopass® 32.5G Pen Needles feature a larger inner diameter for better flow characteristics and less injection pressure. Compatible with insulin and other formulations including hormones, Terumo’s unique asymmetric tip is designed with the aim to reduce pain during insertion by cutting the skin on entry rather than piercing it.

Designed and engineered for subcutaneous injections, Nanopass® 32.5G Needles for pen injectors offer the quality and supply reliability drug developers need to meet drug delivery challenges and product commercialization goals. By offering a range of needles with 4mm, 6mm and 8mm Terumo strives to cover all patient groups.

 
Patient comfort in mind

  • Asymmetric needle tip reduces skin trauma by cutting, not piercing skin on penetration2
  • Smaller overall diameter (32.5G) needle targeted to reduce penetration pressure, especially in longer lengths3

Engineered for automated environments

  • Individually packed and sealed in an ergonomic plastic case for automated assembly and easier patient handling
  • Each length color-coded on the unit pack for easy identification

Regulatory and Quality Aspects

  • E-beam sterilization to a Sterile Assurance Level at least 10-6
  • In compliance with applicable ISO standards and  Pharmacopoeia 
  • CE-marked
  • Proven track record of reliable supply assured by global operating company

General specifications

​Nanopass® 32.5G Pen Needles are intended for use with a pen injector for subcutaneous applications of drugs (ex. insulin and human growth hormone).

Specifications Nanopass® 32.5G      
Needle length4 mm6 mm8 mm
Needle diameter(Ø 0.22 mm)(Ø 0.22 mm)(Ø 0.22 mm)
Package100 pcs
100 pcs100 pcs

Global Solutions
Nanopass® 32.5G Pen Needle solutions are available to drug product manufacturers globally. For more information about product availability, specifications, and applicable standards, download our data sheet or contact your Terumo representative today.

Please note that some products may not be available in all regions, check with your local TERUMO Pharmaceuticals Solutions contact for details.
This product is also available for HCP professionals. Please visit the  Terumo Europe website.

Item specifications

 

Needle
length
Product
code
Packaging
size
4 mmTN*32504M100 pieces Nanopass 4 mm
6 mm TN*32506M100 pieces Nanopass 6 mm
8 mmTN*32508M100 pieces Nanopass 8 mm

Nanopass®32.5G is not sold in North America. 

nanopass_ce_mark adjusted.jpg Does not contain components made of natural rubber latex.

References

1 Patented technology

2 Pen needle design influences ease of insertion, pain and skin trauma in subjects with type 2 diabetes Kezia A Praestmark, 1, E, Morten L Jenzen, 3 Nils B Madsen, 2 JOnas Kildegaard, 4 Bente M Stallknecht 1

3 Data on file

Let’s Find Your Best Solution

Innovation and creativity are central to Terumo Pharmaceutical Solutions’ value proposition. Our expert teams lead the industry in developing and manufacturing advanced, high-performing infusion and injection technologies for all parenteral applications.

Contact Us

Didn't find your product?

Consult our products in our Product Index

Are you a pharmaceutical professional?

This information is intended for professionals in the pharmaceutical supply chain who are interested in primary packaging, injection components and medical devices from Terumo Pharmaceutical Solutions, for use in combination with their respective drug products (hereafter, pharmaceutical professionals). Please note that the product information contained on this website is exclusively addressed to pharmaceutical professionals. This product information is not for the general public, nor is it intended to be a substitute for professional medical advice or for the care that patients receive from their healthcare professionals. By accessing it, you (i) acknowledge having read and understood both the above message and our terms of use and, further, (ii) confirm that you do so in the capacity of a pharmaceutical professional.